Risk of HBV Reactivation in Patients Treated With Immunotherapy for Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Risk of Hepatitis B Virus Reactivation in Patients Treated With Immunotherapy for Anti-cancer Treatment
Clin. Gastroenterol. Hepatol. 2022 Apr 01;20(4)898-907, S Yoo, D Lee, JH Shim, KM Kim, YS Lim, HC Lee, C Yoo, BY Ryoo, J ChoiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.